论文部分内容阅读
目的:了解某院剖宫产围术期抗菌药物应用情况,探讨其合理性。方法:选择2014年9~11月在我院产科行剖宫产术患者179例作为研究对象,采用回顾性调查方法,按照手术部位目标性监测调查表记录患者基本情况、手术情况以及围术期抗菌药物应用情况等,并参照相关规范评价用药的合理性。结果:179例剖宫产术患者,围手术期均预防应用抗菌药物,前3位抗菌药物分别为二代头孢(36.69%)、一代头孢(26.26%)和三代头孢(23.74%);结扎脐带后给药168例占93.85%,术后用药时间≤3d比例为88.20%,用药时间≥6比例为4.49%;术前和术后联合用药分别为1.17%和25.84%。结论:本次监测剖宫产围术期抗菌药物应用存在一定的不合理性,需要进一步规范。
Objective: To understand the application of antimicrobial agents during cesarean section perioperative period in a hospital and discuss its rationality. Methods: A total of 179 cases of cesarean section in obstetrics and gynecology department of our hospital from September to November 2014 were selected as the research objects. The retrospective investigation method was used to record the basic information of patients, operation conditions and perioperative period Antibacterial drug application, etc., and with reference to relevant norms to evaluate the rationality of medication. Results: In the 179 cases of cesarean section, perioperative prevention and treatment of antimicrobial agents were used. The first three antibiotics were cephalosporin second generation (36.69%), cephalosporin first generation (26.26%) and cephalosporin third generation (23.74% After administration of 168 cases accounted for 93.85%, after the medication time ≤ 3d ratio was 88.20%, medication time ≥ 6 ratio was 4.49%; preoperative and postoperative combination drugs were 1.17% and 25.84%. Conclusion: The application of antimicrobial agents for cesarean section during the perioperative period has some irrationality and needs to be further regulated.